Annual CFF:
$515.26M+$63.73M(+14.11%)Summary
- As of today, GPCR annual cash from financing is $515.26 million, with the most recent change of +$63.73 million (+14.11%) on December 31, 2024.
- During the last 3 years, GPCR annual cash from financing has risen by +$412.01 million (+399.02%).
- GPCR annual cash from financing is now at all-time high.
Performance
GPCR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$519.10K-$291.10K(-35.93%)Summary
- As of today, GPCR quarterly cash from financing is $519.10 thousand, with the most recent change of -$291.10 thousand (-35.93%) on June 30, 2025.
- Over the past year, GPCR quarterly cash from financing has dropped by -$513.49 million (-99.90%).
- GPCR quarterly cash from financing is now -99.90% below its all-time high of $514.01 million, reached on June 30, 2024.
Performance
GPCR Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$2.14M-$513.49M(-99.59%)Summary
- As of today, GPCR TTM cash from financing is $2.14 million, with the most recent change of -$513.49 million (-99.59%) on June 30, 2025.
- Over the past year, GPCR TTM cash from financing has dropped by -$795.50 million (-99.73%).
- GPCR TTM cash from financing is now -99.73% below its all-time high of $797.64 million, reached on June 30, 2024.
Performance
GPCR TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GPCR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +14.1% | -99.9% | -99.7% |
| 3Y3 Years | +399.0% | -98.3% | -92.7% |
| 5Y5 Years | +1894.3% | - | - |
GPCR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +1675.9% | -99.9% | +147.6% | -99.7% | at low |
| 5Y | 5-Year | at high | +1894.3% | -99.9% | +134.1% | -99.7% | +240.4% |
| All-Time | All-Time | at high | +1894.3% | -99.9% | +134.1% | -99.7% | +240.4% |
GPCR Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $519.10K(-35.9%) | $2.14M(-99.6%) |
| Mar 2025 | - | $810.20K(+172.7%) | $515.63M(+0.0%) |
| Dec 2024 | $515.26M(+14.1%) | $297.10K(-42.1%) | $515.52M(-35.3%) |
| Sep 2024 | - | $512.90K(-99.9%) | $797.19M(-0.1%) |
| Jun 2024 | - | $514.01M(>+9900.0%) | $797.64M(+182.3%) |
| Mar 2024 | - | $700.90K(-99.8%) | $282.54M(-37.4%) |
| Dec 2023 | $451.53M | $281.97M(>+9900.0%) | $451.14M(+166.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $956.20K(+187.7%) | $169.17M(+0.6%) |
| Jun 2023 | - | -$1.09M(-100.6%) | $168.21M(-16.0%) |
| Mar 2023 | - | $169.30M(+448.0%) | $200.20M(+581.6%) |
| Dec 2022 | $29.01M(-71.9%) | - | - |
| Jun 2022 | - | $30.90M(+2127.3%) | $29.37M(+2027.3%) |
| Mar 2022 | - | -$1.52M | -$1.52M |
| Dec 2021 | $103.25M(+299.6%) | - | - |
| Dec 2020 | $25.84M | - | - |
FAQ
- What is Structure Therapeutics Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. annual cash from financing year-on-year change?
- What is Structure Therapeutics Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. quarterly cash from financing year-on-year change?
- What is Structure Therapeutics Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. TTM cash from financing year-on-year change?
What is Structure Therapeutics Inc. annual cash from financing?
The current annual cash from financing of GPCR is $515.26M
What is the all-time high annual cash from financing for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high annual cash from financing is $515.26M
What is Structure Therapeutics Inc. annual cash from financing year-on-year change?
Over the past year, GPCR annual cash from financing has changed by +$63.73M (+14.11%)
What is Structure Therapeutics Inc. quarterly cash from financing?
The current quarterly cash from financing of GPCR is $519.10K
What is the all-time high quarterly cash from financing for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high quarterly cash from financing is $514.01M
What is Structure Therapeutics Inc. quarterly cash from financing year-on-year change?
Over the past year, GPCR quarterly cash from financing has changed by -$513.49M (-99.90%)
What is Structure Therapeutics Inc. TTM cash from financing?
The current TTM cash from financing of GPCR is $2.14M
What is the all-time high TTM cash from financing for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high TTM cash from financing is $797.64M
What is Structure Therapeutics Inc. TTM cash from financing year-on-year change?
Over the past year, GPCR TTM cash from financing has changed by -$795.50M (-99.73%)